This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04280/identifier/pdb/
n6http://linked.opendata.cz/resource/drugbank/drug/DB04280/identifier/pubchem-compound/
n7http://linked.opendata.cz/resource/drugbank/drug/DB04280/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04280/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04280
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB04280 n13:DB04280
dcterms:title
((2r,3s,5r)-3-Hydroxy-5-(4-Hydroxy-2-Oxo-3,4-Dihydropyrimidin-1(2h)-Yl)-Tetrahydrofuran-2-Yl)Methyldihydrogen Phosphate
adms:identifier
n6:46936941 n7:46505026 n8:DB04280 n9:DDN
n3:IUPAC-Name
n4:271B4B75-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4B7B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4B7A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4B77-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4B78-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4B79-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4B73-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4B74-363D-11E5-9242-09173F13E4C5 n4:271B4B71-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4B72-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4B81-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4B82-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4B7C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4B7D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4B7F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4B7E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4B80-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4B87-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4B89-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4B8A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4B86-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4B85-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4B88-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4B76-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4B83-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4B84-363D-11E5-9242-09173F13E4C5